You are viewing an incomplete version of our website. Please click to reload the website as full version.

14,15-DHET ELISA Kit

Details zu Produkt Nr. ABIN614161, Anbieter: Anmelden zum Anzeigen Neu
Request Mehr Daten zu diesem Produkt gewünscht?

Unabhängige Labortests können diese liefern Mehr

Alle Spezies
Methodentyp Competition ELISA
Pubmed 16 Publikationen vorhanden
Hersteller Anmelden zum Anzeigen Neu
Produkt-ID vom Hersteller Anmelden zum Anzeigen Neu
Menge 96 tests
Lieferung nach Deutschland ( )
Verfügbarkeit Lieferung in 6 bis 8 Werktagen
Sensitivität 10 pg/mL
Produktmerkmale Antibodies for this Kit were raised in Goat.
Hintergrund Competitive ELISA for hypertension
Beschränkungen Nur für Forschungszwecke einsetzbar
Lagerung -20 °C
Produkt verwendet in: Sporková, Kopkan, Varcabová et al.: "Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats." in: American journal of physiology. Regulatory, integrative and comparative physiology, Vol. 300, Issue 6, pp. R1468-75, 2011 (PubMed).

Xiao, Li, Yan et al.: "Overexpression of cytochrome P450 epoxygenases prevents development of hypertension in spontaneously hypertensive rats by enhancing atrial natriuretic peptide." in: The Journal of pharmacology and experimental therapeutics, Vol. 334, Issue 3, pp. 784-94, 2010 (PubMed).

Zheng, Wang, Li et al.: "Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats." in: American journal of respiratory cell and molecular biology, Vol. 43, Issue 6, pp. 740-9, 2010 (PubMed).

Xu, Zhao, Wang et al.: "Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice." in: Diabetes, Vol. 59, Issue 4, pp. 997-1005, 2010 (PubMed).

Certíková Chábová, Walkowska, Kompanowska-Jezierska et al.: "Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats." in: Clinical science (London, England : 1979), Vol. 118, Issue 10, pp. 617-32, 2010 (PubMed).

Merkel, Liu, Cao et al.: "Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling." in: American journal of physiology. Heart and circulatory physiology, Vol. 298, Issue 2, pp. H679-87, 2010 (PubMed).

Eldrup, Soleymanzadeh, Taylor et al.: "Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase." in: Journal of medicinal chemistry, Vol. 52, Issue 19, pp. 5880-95, 2009 (PubMed).

Zhang, Iliff, Campbell et al.: "Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia." in: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, Vol. 29, Issue 8, pp. 1475-81, 2009 (PubMed).

Chen, Li, Liao et al.: "Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo." in: The Journal of pharmacology and experimental therapeutics, Vol. 329, Issue 3, pp. 908-18, 2009 (PubMed).

Zhang, Otsuka, Sugo et al.: "Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia." in: Stroke; a journal of cerebral circulation, Vol. 39, Issue 7, pp. 2073-8, 2008 (PubMed).

Jiang, Ning, Chen et al.: "Cytochrome p450 epoxygenase promotes human cancer metastasis." in: Cancer research, Vol. 67, Issue 14, pp. 6665-74, 2007 (PubMed).

Koerner, Jacks, DeBarber et al.: "Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 27, Issue 17, pp. 4642-9, 2007 (PubMed).

Yang, Lin, Chen et al.: "Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways." in: American journal of physiology. Heart and circulatory physiology, Vol. 293, Issue 1, pp. H142-51, 2007 (PubMed).

Liu, Li, Chao et al.: "Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction." in: Atherosclerosis, Vol. 195, Issue 1, pp. 199-206, 2007 (PubMed).

Jiang, Chen, Card et al.: "Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors." in: Cancer research, Vol. 65, Issue 11, pp. 4707-15, 2005 (PubMed).

Spiecker, Darius, Hankeln et al.: "Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2." in: Circulation, Vol. 110, Issue 15, pp. 2132-6, 2004 (PubMed).

Produktnummer ABIN614161
310,79 €
Zzgl. Versandkosten 20,00 €, Trockeneispauschale 20,00 € sowie MWSt

Bestellen Sie auch über:

  • +49 (0)241 95 163 153
  • +49 (0)241 95 163 155